» Articles » PMID: 1353411

Evidence for a Tumor Suppressor Gene on Chromosome 19q Associated with Human Astrocytomas, Oligodendrogliomas, and Mixed Gliomas

Overview
Journal Cancer Res
Specialty Oncology
Date 1992 Aug 1
PMID 1353411
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown frequent allelic losses of chromosomes 9p, 10, 17p, and 22q in glial tumors. Other researchers have briefly reported that glial tumors may also show allelic losses of chromosome 19, suggesting a putative tumor suppressor gene locus on this chromosome (D. T. Ransom et al., Proc. Am. Assoc. Cancer Res., 32:302, 1991). To evaluate whether loss of chromosome 19 alleles is common in glial tumors of different types and grades, we performed Southern blot restriction fragment length polymorphism analysis for multiple chromosome 19 loci in 122 gliomas from 116 patients. Twenty-nine tumors had loss of constitutional heterozygosity of 19q, and four tumors had partial deletions of 19q. Allelic losses on 19q were restricted to grade III anaplastic astrocytomas (4/9) and grade IV glioblastomas (11/46), grade II oligodendrogliomas (2/5) and grade III anaplastic oligodendrogliomas (2/2), and grade II (5/8) and grade III (5/7) mixed oligoastrocytomas. These data demonstrate genetic similarities between astrocytomas, oligodendrogliomas, and mixed glial tumors and indicate the presence of a glial tumor suppressor gene on chromosome 19q.

Citing Articles

Identification of mitophagy-related genes impacting patient survival in glioma.

Zhao Q, Li G Discov Oncol. 2025; 16(1):140.

PMID: 39923213 PMC: 11807950. DOI: 10.1007/s12672-025-01916-6.


Chromosome 1p deletion in colorectal cancer and lower grade glioma: possible relationship with the enteric nervous system.

Lehrer S, Rheinstein P medRxiv. 2024; .

PMID: 38196589 PMC: 10775321. DOI: 10.1101/2023.11.07.23298214.


Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells.

Ham S, Kim J, Seo S, Hong N, Park M, Kim Y Int J Mol Sci. 2023; 24(19).

PMID: 37834227 PMC: 10573421. DOI: 10.3390/ijms241914776.


TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I.

Fei X, Wu X, Dou Y, Sun K, Guo Q, Zhang L Mol Ther Oncolytics. 2022; 26:413-428.

PMID: 36159777 PMC: 9465028. DOI: 10.1016/j.omto.2022.08.007.


Comparative analysis of transcriptomic profile, histology, and IDH mutation for classification of gliomas.

Tran P, Tran L, Nechtman J, Santos B, Purohit S, Bin Satter K Sci Rep. 2020; 10(1):20651.

PMID: 33244057 PMC: 7692499. DOI: 10.1038/s41598-020-77777-6.